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Abstract 
 
We have previously demonstrated that epigenetic silencing of occludin, a tight 
junction-associated membrane protein, results in the acquisition of apoptotic resistance to 
various apoptogenic stimuli, causally contributing to the enhanced tumorigenicity of cancer 
cells.  However, it remains to be examined whether occludin expression in transformed cells 
has an alternative impact that is important for cancer progression.  Here we show that forced 
expression of occludin induces anoikis and promotes oxidative stress-induced premature 
senescence in breast carcinoma cells, which is accompanied by up-regulation of negative cell 
cycle regulators such as p16INK4A, p21Waf1/Cip1, and p27Kip1, but not p53.  The senescent 
phenotype is reversed by specific inhibition of mitogen-activated protein kinase.  
Endogenous reexpression of occludin mediated by a synergistic effect with a demethylator 
and histone deacetylase inhibitor or retinoids that stimulate retinoic acid receptor  is also 
sufficient for provoking the senescent phenotype.  In addition, tumors that developed from 
occludin-expressing cells in mice showed a feature of cellular senescence that has not been 
described as a consequence of occludin signaling.  These findings suggest that the loss of 
occludin expression is at least partially involved in the senescence-escape program during 
mammary tumorigenesis. 
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Introduction 
 
 Four decades ago, the phenomenon of “replicative senescence” was described as a 
process leading to irreversible arrest of cell division in which metabolically active cultured 
human fibroblasts lost the ability to divide upon continuous subculture.(1)  While 
“replicative senescence” is triggered by progressive telomere shortening, an indistinguishable 
phenotype, termed “premature senescence”, can be acutely produced by a number of cell 
stresses, including oxidative stress, DNA damage-inducing agents, and enforced in vitro 
activated oncogenes.(2)  Senescent cells show characteristic changes in cell morphology such 
as a flattened and vacuole-rich cytoplasmic shape, and biochemical characteristics such as 
elevated protein levels of cell cycle inhibitors, including p16 and p21, as well as the 
upregulation of senescence-associated β-galactosidase (SA-β-gal) activity and reciprocal 
negativity for the proliferation marker Ki67.(3-5)  Accumulated evidence has revealed that 
cellular senescence terminates carcinogenesis in a variety of cancer tissues in vitro and in 
premalignant lesions.(5)  However, the physiological relevance of acutely inducible 
premature senescence has remained controversial for years, in sharp contrast to the confirmed 
concepts that impaired or decreased responses to various apoptotic signals are associated with 
oncogenic transformation.(6,7)  Recent reports have now clarified that cellular senescence is 
an intrinsic cell stress-responsive cell cycle exit program, which is regarded as an 
anti-oncogenic fail-safe mechanism to prevent oncogenic activity in aged or potentially 
damaged cells, and a natural barrier to cancer progression.(4,8,9) 
 Tight junctions (TJs) are intercellular structures in epithelial and endothelial cells, 
primarily playing a critical role in cell-cell adhesion.(10,11)  Occludin was the first identified 
requisite integral protein for the TJ, but occludin-deficient cells and animals have fully 
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developed well-organized TJs structurally.(12-14)  Thus it is now well accepted that the 
claudin family, which has been shown to contain more than 20 members, is the main 
constituent of the TJ, rather than occludin.(11)  We have also demonstrated that the 
methylator phenotype of occludin exhibits decreased cellular sensitivity to various differently 
triggered apoptogens, causally enhancing the tumorigenic properties of the transformed 
cells.(15)  In addition, a growing body of evidence has indicated that cancer progression is 
associated with decreased and/or impaired TJ phenotypes, and that the loss of TJ-associated 
molecules such as occludin is generally correlated with tumor development in 
carcinogenesis.(15-18)  These findings suggest that occludin is not a simple static component 
of TJs but has functions in receiving and transmitting cell survival signals, eventually acting 
as a signal transmitter for the cells at TJs during the carcinogenic scenario. 
 Based on accumulating evidence concerning occludin, we investigated whether 
occludin expression in cancer cells had any alternative impact that was important for cancer 
progression.  Here we demonstrate that the expression of occludin in transformed cells 
induces anoikis in three-dimensional culture of breast carcinoma cells.  In addition, the 
cellular response in the event of occludin expression shows features of premature senescence, 
accompanied by upregulation of negative cell cycle regulators such as p16INK4A, p21Waf1/Cip1, 
and p27Kip1, but not p53.  Our observations support the idea that occludin expression in 
cancer cells is at least partially involved in a senescence-promoting mechanism that may 
prevent abnormal cells from entering the carcinogenic program during mammary 
tumorigenesis. 
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Materials and Methods 
 
Cell line and transfection.  AC2M2, a metastatic variant of murine breast cancer cell line 
SP1, and SP1 were isolated from a mammary intraductal adenocarcinoma that arose 
spontaneously in an 18-month-old CBA/J female retired breeder mouse.(19)  AC2M2 cells 
were maintained in DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% FBS (Sanko 
Jyunyaku, Tokyo, Japan), 10 mM HEPES, 100 U/ml penicillin, and 100 μg/ml streptomycin 
at 37C in a humidified 5% CO2 atmosphere. 
 Five g of pcDNA3.1(-)-occludin, which is a construct cloning full-length murine 
occludin cDNA into the response plasmid pcDNA3.1(-) (Invitrogen), was transfected into 
AC2M2 cells using FuGENE 6 reagent (Roche, Indianapolis, IN).  G418 (Sigma, Tokyo, 
Japan)-resistant clones were expanded as a monoclonal population.  Three weeks later, cell 
lines were selected to examine the strength of the expression of the introduced gene by 
quantitative reverse transcription (RT)-PCR and Western blot analysis.  Since our 
preliminary experiment showed that phenotypes of the cells observed in the event of occludin 
overexpression were similar but not the same in at least 3 different independent clones, these 
cells were equally mixed to establish stably transfected cell lines and to avoid possible clonal 
variation.  Small interfering RNA (siRNA) targeted to occludin or negative control siRNA 
(both from Santa Cruz Biotechnologies, Santa Cruz, CA) was also transfected into the cells 
using FuGENE 6 reagent (Roche). 
 
Cell death analyses.  Cell death was induced by preventing cells from adhering to the 
plastic of cell culture dishes.(15)  In some experiments, 100 nM all-trans retinoic acid 
(atRA)(Sigma) was added and maintained throughout the experiments.  Fragmented DNA 
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from dead cells was isolated according to a method that preferentially extracted low 
molecular weight cellular DNA.(15)  Gel electrophoresis of the DNA samples was performed 
on 2.5% agarose gels and ladder formation due to fragmentation was visualized with 
ethidium bromide under ultraviolet illumination. 
 
Senescence-associated β-galactosidase staining.  The cells were exposed to mild oxidative 
stress under 25 μM H2O2 for up to 5 days, and senescent cells were visualized by SA-β-gal 
staining.(3)  The tumors that developed in the mouse subcutaneous tissue were also subjected 
to this assay.  The cells positively stained by the specified procedures were scored using 
light microscopy by counting the number of cells under low magnification (x 100) in 10 
separate arbitrarily selected fields in each section.  In some experiments, atRA (100 nM), 
4(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtamido)benzoic acid (Am580, 10 nM), a 
mitogen-activated protein kinase (MAPK) inhibitor (PD98059, 50 M, 
Calbiochem-Novabiochem, San Diego, CA), p38 MAP kinase inhibitor (SB203580, 20 M, 
Calbiochem-Novabiochem), or phosphoinositide-3-kinase (PI3K) inhibitor (LY294002, 20 
M, Calbiochem-Novabiochem) was added and maintained throughout the experiments.  To 
examine the effect of a demethylating agent, the cells were treated with 
5’-aza-2’deoxycytidine (5’Aza-dC, 0-5 M, Sigma) for 48 h, after which a histone 
deacetylase inhibitor (HDAI) or trichostatin A (TSA, 0-300 nM, Sigma) was added, followed 
by incubation for an additional 24 h at 37C. 
 
RT-PCR and Southern blot analysis.  Subsequent to each RT-PCR analysis, to allow for 
semiquantitative analysis of signal intensity, we carried out Southern blot analysis using a 
probe with the full-length cDNA of each gene.(15)  Ribosomal RNA (rRNA) was shown to 
 7
use the same amounts of RNA for RT reactions.  Triplicate independent PCR reactions were 
carried out to ensure the reproducibility of expression quantification.  For the densitometric 
analysis, signals were quantitated using Scion Image 1.62 (Scion, Frederick, MD).  
Oligonucleotide sequences of all primers used for the PCR reactions are available on request. 
 
Western blot analysis.  Whole cell lysates (20 g) of denatured proteins were run on 
12-15% SDS-PAGE and electroblotted onto nitrocellulose filters.  Filters were 
immunoblotted with antibodies against occludin (Zymed Laboratories, San Francisco, CA), 
p16INK4A, p21Waf1/Cip1, p27Kip1 (all from Santa Cruz), p53 (Oncogene, San Diego, CA), and 
-actin (Santa Cruz) proteins.  The filters were then reacted with corresponding 
peroxidase-labeled secondary antibodies; finally, the immunoreactions were visualized using 
an enhanced chemiluminescence (ECL) system (GE Healthcare, Piscataway, NJ). 
 
TUNEL assay and immunohistochemistry.  Cells cultured on collagen coated-glass 
coverslips were subjected to the terminal deoxynucleotidyl transferase-mediated nick end 
labeling (TUNEL) assay.  Apoptotic cells were visualized using an In Situ Cell Death 
Detection Kit (Roche).  We also carried out a staining procedure other than for TdT as a 
negative control.  For immunohistochemistry, the cells on a coverslip were reacted with the 
primary antibody against Ki67 (Dako Cytomation, Tokyo, Japan).  Cells positively stained 
by the specified procedures were scored using light microscopy by counting the number of 
cells under low magnification (x 100) in 10 separate arbitrarily selected fields in each section.  
Staining for actin filaments was done with rhodamine-phalloidin (1 unit/slide, Molecular 
Probes, Eugene, OR).  All samples were examined with a fluorescence microscope (Zeiss, 
Tokyo, Japan) or a laser-scanning confocal microscope (Bio-Rad, Hercules, CA). 
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Cell cycle analysis by flow cytometry.  Cells were treated with 25 μM H2O2 for 5 days 
prior to harvesting by centrifugation, and permeabilized with ice-cold 70% ethanol for 10 min.  
After washing with PBS, cells were treated with PBS containing 100 g/ml DNase 
free-RNase A at 37C for 30 min.  After centrifugation, cells were suspended in PBS 
containing 1 g/ml (4’,6-diamidino-2-phenylindole)-methanol (DAPI) solution for 15 min.  
DNA content was analyzed by FACScan (Becton Dickinson, Tokyo, Japan). 
 
Tumor growth in vivo.  We subcutaneously injected cells of AC2M2 and its transfectant 
(7.5 x 103 cells/mouse) into mammary fat pads of syngenic 6-7-week-old female mice 
(CBA/J, Charles River Japan, Yokohama, Japan).(15)  The handling of animals was carried 
out using protocols approved by the Sapporo Medical University Animal Care Facility. 
 
Statistical analysis.  All data represent the mean  SD of at least 3 independent experiments, 
each in triplicate wells.  Statistical differences were analyzed using the paired t test, and 
were considered significant when p<0.05.
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Results 
 
Forced expression of occludin promotes anoikis.  We established two AC2M2 murine 
breast carcinoma cell lines constitutively overexpressing wild-type (wt) occludin, designated 
AC2M2-Oc#1 and AC2M2-Oc#2, as a result of 2 independent transfections.  AC2M2 cells 
transfected with an empty vector were used as a control (AC2M2-Vec).  While endogenous 
expression of occludin was not detectable in AC2M2-Vec cells by Western blot analysis, 
RT-PCR-Southern blot analysis demonstrated that AC2M2-Vec expressed appreciable 
amounts of endogenous occludin (Fig. 1a).  AC2M2-Oc#1 and #2 cells abundantly 
expressed occludin mRNA, and AC2M2-Oc#2 showed higher expression of occludin than 
AC2M2-Oc#1 (Fig. 1a).  Our preliminary experiments revealed that occludin 
overexpression had significant effects both on AC2M2-Oc#1 and AC2M2-Oc#2 cells, but 
AC2M2-Oc#2 showed more marked changes in each variable than AC2M2-Oc#1 when 
compared with the AC2M2-Vec cells.  We thus used AC2M2-Oc#2 cells, hereafter 
designated AC2M2-Oc, in the following studies. 
 Breakdown of anoikis (anchorage dependency-mediated apoptotic cell death) may be 
a predominant contributor to oncogenic progression.(6)  In addition, our previous study has 
shown that the various cell lines overexpressing occludin gain significant sensitivity to a 
number of apoptogenic stimuli.  We therefore examined whether occludin overexpression 
promoted anoikis in AC2M2 cells (Fig. 1b).  Prior to the apoptotic stimulation, the media 
used for AC2M2-Vec and AC2M2-Oc cells were changed to media without FBS 
supplementation in the presence or absence of 1 M atRA as an apoptotic sensitizer.(20)  
DNA fragmentation analysis demonstrated that forced expression of occludin clearly 
enhanced the sensitivity to anoikis, and AC2M2 cells that had higher expression of occludin 
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showed increased sensitivity to apoptosis (Fig. 1b).  TUNEL assay also revealed that atRA 
increased the sensitivity to anoikis both in AC2M2-Vec and AC2M2-Oc cells, and that 
occludin and atRA additively increased anoikis in AC2M2-Oc cells (Fig. 1c).  Based on our 
observation that occludin-specific siRNA efficiently suppressed occludin expression in 
AC2M2-Oc cells (Fig. 1d), we found that the transfection with this siRNA partially but 
significantly inhibited occludin-mediated enhancement of cell death in occludin-expressing 
cells (Fig. 1c), suggesting a direct mechanistic link between occludin expression and 
apoptotic sensitization.  Importantly, the atRA-induced increase of apoptotic sensitivity was 
suppressed by siRNA-mediated silencing of occludin (Fig. 1c), supporting our previous 
finding that endogenous occludin induced by atRA could enhance apoptotic sensitivity to 
apoptogenic stimuli.(15) 
 Since occludin expression affects a wide variety of genes associated with the 
components of the apoptotic machinery, we next examined the gene-expression alterations in 
the event of occludin overexpression in AC2M2 cells (Fig. 1e).  Changes in the pattern of 
gene-expression were consistent with the gene-expression profiles determined by an 
apoptosis pathway-specific gene array,(15) in which occludin expression downregulated a 
number of apoptosis-inhibitory genes such as bcl-2 and survivin, but conversely upregulated 
apoptosis-inducing genes such as apaf-1and bax.  Genes involved in the apoptosis-executing 
pathway such as caspase 3 were also affected, consistent with the altered phenotype mediated 
by occludin. 
 
Occludin expression induces premature senescence in AC2M2 cells.  Premature 
senescence is a genetically encoded intrinsic fail-safe mechanism that has to be overcome by 
the further acquisition of oncogenic activities during carcinogenesis.(4,8,9)  We next 
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examined the effect of occludin on cellular senescence as assessed by determining the 
SA-β-gal enzymatic activity.(3)  When the cells were exposed to a mild oxidative stress that 
was insufficient to induce apoptotic cell death even in AC2M2-Oc cells, the 
occludin-expressing cells exhibited prominent phenotypic alteration, showing cytoplasmic 
protrusions and enlarged flat morphology with multiple vacuoles (Fig. 2a).  In addition, the 
percentage of positive reactions to SA-β-gal activity was significantly high in AC2M2-Oc 
cells (Fig. 2a and 2b).  Interestingly, SA-β-gal positive AC2M2-Oc cells were significantly 
decreased after treatment with occludin-specific siRNA (Fig. 2b and 2c), suggesting that 
occludin was associated with the signaling program to induce premature senescence.  We 
should note here that AC2M2-Oc cells required 24 h for maximum reduction of occludin 
after being transfected with occludin-specific siRNA, and significant suppression of occludin 
expression was observed for 5 days (Fig. 2c).  We could not exclude the possibility that 
forced expression of occludin might have as yet unidentified effects on the cells.  However, 
the treatment with atRA increased the number of SA-β-gal positive cells both in AC2M2-Vec 
and AC2M2-Oc and siRNA targeted to occludin abrogated this effect, indicating that 
atRA-mediated upregulation of endogenous occludin was functional in inducing premature 
senescence in the transformed cells.  Observed phenotypes of the cells in the event of 
occludin expression were not cell-type specific, because we obtained similar data from 3 
different cell types (data not shown).   
 
Occludin expression induces growth arrest under oxidative stress.  To study the effect 
of occludin signaling on proliferation in AC2M2 cells, cell growth was analyzed in a 
time-dependent manner.  Manual cell counting every 24 h up to day 6 after plating equal 
numbers of cells showed no significant differences in the growth and DNA synthesis rate, 
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whereas AC2M2-Oc cells that were exposed to oxidative stress demonstrated significant 
decreases both in the cell growth and DNA synthesis rate (Fig. 2d).  Prolonged incubation 
with H2O2 or incubation with higher concentrations of H2O2 did not result in any further 
decrease of actively proliferating cells, because AC2M2-Oc cells underwent apoptotic cell 
death under these conditions.  In addition, cell cycle analyses indicated that occludin 
expression induced G1 arrest and a concomitant decrease in S-phase fractions in response to 
oxidative stress in AC2M2-Oc cells (Fig. e), suggesting that occludin-induced cellular 
senescence involved the G1/S phase transition and might sensitize cells to mitogen-mediated 
specific cell cycle checkpoints.  Cell cycle inhibitors such as cyclin-dependent kinase 
(CDK) inhibitors, including p16INK4A, p21Waf1/Cip1, p27Kip1, and p53, are key mediators of the 
cellular premature senescence program characterized by cell cycle arrest.  We next 
examined the expression alterations of CDK inhibitors in the event of occludin 
overexpression in AC2M2 cells under oxidative stress (Fig. 2f).  Western blot analysis 
revealed no significant differences in protein levels between AC2M2-Vec and AC2M2-Oc 
cells without incubation with H2O2, whereas protein increases of p16INK4A, p21Waf1/Cip1, 
p27Kip1, but not p53, were observed in the presence of H2O2.  Withdrawal of the oxidative 
stress did not result in the release of cell cycle block and the induction of apoptosis.  These 
data provided further support for the possibility that occludin signaling enhanced part of the 
premature senescence program initiated in response to the cell stressors. 
 
Mitogen-activated protein kinase mediates the induction of senescence in 
occludin-expressing cells.  The COOH-terminus of occludin is known to be important in its 
function, which is responsible for the transmission of various signaling pathways such as 
MAPK.(10,11,15,21)  Consistent with this, deletion mutants with various COOH-terminal 
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truncations (Fig. 3a) had no effects on increasing SA-β-gal positive cells in response to 
oxidative stress (Fig. 3b), suggesting that the 44 amino acids (aa) at the COOH-terminal end 
of occludin were responsible for the regulation of cellular senescence.  We next examined 
the signal transduction pathway(s) involved in the occludin-mediated premature senescence 
by using small-molecule protein kinase inhibitors designed to specifically block signal 
constituents of protein kinase cascades.  A MAPK inhibitor (PD98059) partially but 
significantly abrogated the enhancement of premature senescence mediated by occludin 
overexpression, whereas other inhibitors such as a p38 MAPK inhibitor (SB203580) and 
PI3K inhibitor (LY294002) had no effect (Fig. 3c), suggesting that active engagement of 
pMAPK signaling molecules was necessary to provoke the cellular senescence program as a 
result of the activation of occludin signaling. 
 
Occludin signaling induces cell spreading.  Accumulated evidence has demonstrated that 
senescent cells not only have different gene-expression patterns when compared with 
reversibly arrested quiescent cells, but also display characteristic morphologic changes.(9)  
To determine the morphological alterations induced in AC2M2 cells by occludin 
overexpression, we examined the cells with phase-contrast microscopy at various times (30 
min to 6 h) after plating the cells (Fig. 4a and 4b).  Cell shape was indistinguishable 
between AC2M2-Vec and AC2M2-Oc cells, which were regularly round, after 10 min in 
culture.  Cytoplasmic protrusions were observed at 30 min and the cell shape became 
significantly different after 1 h in occludin-expressing cells.  The size of the AC2M2-Oc 
cells increased and they became flattened after 1 h.  These differences had gradually 
increased at 6 h after seeding the cells.  After 6 h, a large number of occludin-expressing 
cells had actin stress fibers, though these were detected only in a few AC2M2-Vec cells (Fig. 
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4c).  Occludin-mediated cell spreading is partially explained by the evidence that occludin 
directly associates with cytoplasmic scaffolding proteins, submembrane components of TJs, 
thereby providing a direct linkage to the actin cytoskeleton,(11) and that morphological 
changes in the cells usually depend on the alterations of actin stress fiber formation.(22) 
 
Endogenous occludin is sufficient for provoking cellular senescence.  To exclude the 
possibility that the forced expression of occludin resulted in unidentified artifacts in the cells, 
we next used a demethylator (5’Aza-dC) and HDAI (TSA) or retinoids that stimulated RARα 
to induce endogenous occludin expression in the AC2M2 cells (Fig. 5a), in which CpG 
islands of the occludin promoter were shown to be densely methylated.(15)  Although 
SA-β-gal enzymatic activity is a good marker to measure cellular senescence, positive 
staining using this assay has been observed in cases of cellular stress unrelated to 
senescence.(23)  Thus, senescence was also verified by scoring for the maker Ki67.(5, 9)  
Either 5’Aza-dC or TSA alone or in synergy with these agents, as well as the RARα stimulant 
was sufficient for increasing the SA-β-gal positive cells, and conversely for decreasing the 
Ki67 positive cells (Fig. 5b and 5c).  Importantly, transfection of occludin-specific siRNA 
partially but significantly abrogated the increases of SA-β-gal positive cells and the decreases 
of Ki67 positivity mediated by the treatment with 5’Aza-dC/TSA and RARα.  Our data 
suggested that the altered phenotypes induced by the treatment with these reagents were, at 
least in part, responsible for the endogenous reexpression of occludin. 
 
Occludin expression induces senescent phenotype in vivo.  We next investigated whether 
occludin could induce cellular senescence in vivo.  SA-β-gal staining revealed diffuse strong 
positive reactivity in tumors that developed from AC2M2-Oc cells (Fig. 6a and 6b).  
 15
Conversely, cellular proliferation rates assessed by Ki67 labelling indexes were significantly 
suppressed in occludin-expressing cells.  On the other hand, positive staining was not 
observed in the normal mammary gland or any tumors that developed from AC2M2-Vec 
cells, suggesting that occludin signaling was involved in part of the senescence machinery in 
vivo under physiological cell stress. 
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Discussion 
 
 Herein we shed light on the novel functions of occludin in cancer cells, which have 
not hitherto been described as a consequence of occludin signaling, demonstrating that the 
loss of occludin expression is at least partially involved in the senescence-escape program 
during mammary tumorigenesis.  While accumulating studies have shown the 
downregulation of TJ-associated proteins such as occludin during carcinogenesis in many cell 
types,(15-18) the impact of our findings on breast cancer seems to be limited due to the fact that 
epigenetic silencing of occludin has not been demonstrated to occur during human breast 
cancer progression.  However, we provided clear evidence that occludin expression in a 
number of transformed cells showed cellular features of premature senescence that can be 
triggered when cells are exposed to cell stressors.  Although the underlying mechanism 
explaining how occludin determines the fate of cancer cells (i.e. apoptotic or senescence) in 
response to cell stressors remains to be clarified, it is possible that cell fate decision is made 
depending on the cell type, the type of cell stress, the strength and duration of the stress, and 
the cell-surrounding microenvironment, as well as on the integrity of tumor suppressor genes. 
 We found that occludin was associated with a number of apoptosis-associated genes 
and the components of the lipid signaling pathway such as MAPK.  In support of these 
observations, the Ras/Raf oncogene-ERK (extracellular signal-regulated kinase)/MEK 
(MAPK/ERK kinase) cascade is of critical importance to show that this protein elicits growth 
arrest and premature senescence in a variety of cell types.(2,24,25)  We also demonstrated that 
the COOH-terminal end of occludin played an important role in inducing cellular senescence.  
This is supported by a number of reports showing that the components of lipid signaling 
interact with the COOH-terminal region of occludin and mediate cell growth and 
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differentiation.(26-28)  It is somewhat surprising that the TJ-associated gene occludin is able 
to induce premature senescence in tumor cells.  Given the extensive range of physiological 
activities of occludin at TJs, it is feasible that occludin is not a simple static component of TJs, 
but has functions in receiving and transmitting cell survival signals, working as a signal 
transmitter located at the TJ in the cell.  This explanation is supported by evidence that 
occludin directly associates with different types of signaling transduction, and TJ protein 
directly participates in the control of gene expression via the modulation of transcription 
machinery in the nucleus.(11,29)  Recent study has also shown that the second extracellular 
loop of occludin is a transforming growth factor-beta (TGF-β) receptor, and occludin 
regulates TGF-β type I receptor localization for efficient TGF-β-dependent dissolution of TJs 
during epithelial-mesenchymal transition, which is a cellular transformation crucial for the 
progression of many epithelial tumors.(30)  Consistent with this view, the possible 
mechanisms underlying premature senescence with high expression of CDK inhibitors caused 
by forced expression of occludin appear to be explained by the signal transduction from 
membrane-anchored occludin to the nucleus. 
 Non-cytotoxic cell stress induces premature senescence that is characterized by 
upregulation of negative cell cycle regulators.  Conversely, cell cycle inhibitors are able to 
provoke the senescent phenotype when, for example, they are ectopically overexpressed in 
early passage human diploid fibroblasts.(31)  Indeed, our observations showed that 
occludin-mediated premature senescence was accompanied by upregulation of p16INK4A, 
p21Waf1/Cip1, and p27Kip1.  CDK inhibitors are key mediators of growth arrest in the course of 
premature senescence, and are implicated in DNA repair to prevent potentially damaged cells 
from undergoing consequent mitotic catastrophe.(9,24)  Whether upregulation of CDK 
inhibitors directly contributes to the senescence-associated phenotype in occludin-expressing 
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cells remains to be determined, but it is possible that occludin provokes premature senescence, 
potentially associated with the enhanced expression of CDK inhibitors.  On the other hand, 
we did not observe expression-alteration in p53 protein in the course of premature senescence, 
suggesting that the senescence induced by occludin signaling was mediated by 
p53-independent mechanisms and/or mutant p53.  The functional requirements for the CDK 
inhibitors in the senescent state appeared to be heterogeneous in the examined 
conditions.(24,25,31)  For example, a p53-independent senescence mechanism was proposed in 
response to hypermitogenic proto-oncogene ERBB2 signaling in breast carcinoma cells,(32) 
though p53 protein is believed to act as an integrator of cell signals for convergence of a 
broad range of different stressors.  Another example was presented by SA-β-gal positivity in 
clinical breast cancer showing that chemotherapy-induced DNA damage was able to induce 
senescence in vivo, but that SA-β-gal staining was associated with low p53 staining.(33) 
 Recently, senescent IMR90 human fibroblasts have been shown to accumulate a 
distinct heterochromatin structure, which is designated senescence-associated 
heterochromatin foci (SAHF).(34)  We did not observe the characteristic features of SAHF 
during the experiment, and cannot presently explain this observation; however, one 
possibility is that a lack of intact Rb signaling (and disruption of the p53 pathway) may have 
limited the ability of occludin-expressing AC2M2 cells to display SAHF in response to the 
oxidative stress.  Our explanation is supported by the fact that SAHF formation primarily 
depends on the integrity of the Rb pathway, and eventually involves the combined activities 
of the Rb/p16INK4a pathway, p53 signaling, and the promyelocytic leukemia protein.(34)  In 
addition, Rb is not essential for all aspects of the senescence program, including the 
characteristic morphological changes, the accumulation of SA-β-gal activity, and the 
irreversible exit from the cell cycle.(34)  We observed that occludin expression in AC2M2 
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cells promoted oxidative stress-induced premature senescence, which apparently did not 
involve SAHF, whereas this was accompanied by up-regulation of negative cell cycle 
regulators and, importantly, withdrawal of the oxidative stress did not result in the release of 
cell cycle block.  These features appear to be sufficient to distinguish senescence from 
quiescence, a nonproliferative state that is reversed in response to mitogens. 
 This study provides significant evidence that occludin signaling is potentially 
associated with premature senescence machinery.  It is now well-accepted that the 
senescence process is an antioncogenic fail-safe mechanism that may function as a natural 
brake to tumor development, sharing therapeutic similarities with apoptotic machinery.(9,35)  
Surprisingly, a number of reports have successfully demonstrated that DNA-damaging agents 
induce cellular senescence that lacks intact apoptotic responsiveness.(33,36)  We thus believe 
that occludin-mediated induction of cellular senescence can be applied as an anti-cancer 
mechanism to blunt oncogenic activity by inducing the cancer cells to exit uncontrolled 
cellular proliferation before expanding as a clinically relevant tumor mass.  While 
overexpressed protein products or misfolded ones left in the endoplasmic reticulum cause 
cellular stress, which may consequently have an impact on intracellular signaling, a more 
important issue was addressed by our observation demonstrating that endogenous 
re-expression of occludin mediated by a synergistic effect with a demethylator and HDAI or 
retinoids that stimulated RAR was sufficient to provoke the senescent phenotype in breast 
carcinoma cells.  Given the conceptual similarity to the apoptotic machinery, occludin is 
thus an appropriate therapeutic target even for cancer cells that do not have detectable 
expression of endogenous occludin. 
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Figure legends 
 
Figure 1.  Forced expression of occludin results in enhanced sensitivity to anoikis in 
AC2M2 cells.  (a) RT-PCR-Southern blot analysis (upper panel) and Western blot analysis 
(lower panel) to show the expression of occludin in AC2M2-Vec (Vec), and constitutively 
overexpressed wt occludin in AC2M2-Oc#1 (Oc#1) and AC2M2-Oc#2 (Oc#2) cells.  (b and 
c) Anoikis was induced after adding cells to agarose-coated dishes to avoid cell attachment.  
DNA laddering analysis to confirm apoptotic cell death (b).  Quantification of anoikis in the 
presence or absence of 1 M atRA as an apoptotic sensitizer in combination with or without 
occludin-specific (Oc) or negative control (Neg) siRNA as determined by TUNEL assay (c).  
siRNA (100 nM) was transfected 48 h before anoikis induction.  *: p<0.05 vs. cells without 
siRNA transfection.  (d) Western blot analysis confirmed the silencing effect of 
occludin-specific siRNA (Oc) in AC2M2-Oc#2 cells (Oc#2), but negative control siRNA 
(Neg) had no effect on the cells.  (e) Occludin expression affects the gene expression 
involving apoptotic machinery.  RT-PCR-Southern blot analysis of indicated 
apoptosis-associated genes in AC2M2-Vec (Vec) and AC2M2-Oc#2 (Oc) cells. 
 
Figure 2.  Occludin induces premature senescence in AC2M2 cells under oxidative stress.  
(a and b) AC2M2-Vec (Vec) and AC2M2-Oc (Oc) cells were exposed to 25 μM H2O2 for up 
to 5 days in the presence or absence of 1 M atRA in combination with or without 100 nM 
occludin-specific (Oc) or negative control (Neg) siRNA, and stained for SA-β-gal.  Note the 
blue cytoplasmic stain in occludin-expressing cells after 3-day exposure to oxidative stress 
(a), and quantification of SA-β-gal positive cells (b).  Bar, 40 μm.  (c) Western blot 
analysis confirmed the silencing effect of occludin-specific siRNA in AC2M2-Oc cells 
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throughout the experiment.  (d) Cell proliferation assay in AC2M2-Vec (Vec, open symbol) 
and AC2M2-Oc (Oc, filled symbol) cells with (right panel) and without (left panel) 25 μ M 
H2O2 for up to 6 days.  Insets show the Ki67 labelling indexes at day 6.  (e) Flow 
cytometric analysis of AC2M2-Vec (Vec) and AC2M2-Oc (Oc) cells after treatment with 25 
μM H2O2 for 3 days.  The mean percentage of cells in each cell cycle fraction from 
independent triplicate experiments is indicated below the histogram.  (f) Western blot 
analysis of cell cycle inhibitors in the presence of 25 μM H2O2 for 3 days.  Densitometric 
analyses for independent triplicate experiments are show below the representative images.  *, 
p<0.05 vs. cells without siRNA (b, c) or occludin transfection (d, f). 
 
Figure 3.  Occludin-mediated premature senescence is associated with the MAPK signaling 
pathway.  (a) Constructs of deletion mutants used to identify the gene regions responsible 
for the cellular senescence were as follows: Oc522aa, full-length murine occludin cDNA 
(coding region from nucleotides 223 to 1788 [occludin223-1788], encoded 522 aa polypeptide; 
GeneBank accession number, U49185); Oc478aa, occludin construct without 44 aa in the 
COOH-terminal end; Oc364aa, occludin construct without 158 aa in the COOH-terminal end; 
Oc158aa, occludin construct with only the cytoplasmic region cloned.  Membrane 
localizations were determined by distribution of EGFP signals under fluorescent microscopy 
after transient transfection with each deletion mutant linked to EGFP (left panel).(15)  
Transfected genes were examined by quantitative RT-PCR using primer sets that amplified 
the non-cytoplasmic domain (primer set A) or cytoplasmic domain (primer set B) of occludin 
(right panel), showing that all of the introduced genes were overexpressed in the cells when 
compared with the vector-transfected cells.  (b) AC2M2 cells transfected with the constructs 
having various deletions in the COOH-terminal domain were exposed to 25 μM H2O2 for 5 
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days, and stained for SA-β-gal.  (c) Effects of three kinase inhibitors on cellular senescence 
in AC2M2-Vec (Vec) and AC2M2-Oc (Oc) cells.  The cells were treated with PD98059, 
SB203580, or LY294002 for 24 h prior to stimulation with oxidative stress.  Oxidative 
stress was induced by exposure to 25 M H2O2 for 5 days and cells were then stained for 
SA-β-gal.  *, p<0.05 vs. cells without occludin transfection (b) and the treatment (c). 
 
Figure 4.  Cell spreading is induced by occludin expression.  (a) Morphological changes of 
AC2M2-Vec (Vec) and AC2M2-Oc (Oc) cells examined by phase-contrast microscopy at 
indicated time points.  Bar, 20 μm.  (b) Quantification of cell spreading of cultured cells.  
The number of spreading cells was evaluated by phase-contrast microscopy in AC2M2-Vec 
(open column) and AC2M2-Oc (filled column) cells, and we categorized cells into three 
groups: round (a), partially spread (b), and fully spread (c).  The results were obtained as the 
percentage of the cells by counting the cell number under low magnification (x 100) in 10 
separate arbitrarily selected fields in each section.  *: p<0.05 vs. cells without occludin 
transfection.  (c) The cells were stained with rhodamine-phalloidin to detect the actin stress 
fibers by fluorescent microscopy.  Bar, 5 μm. 
 
Figure 5.  Endogenous occludin is able to promote cellular senescence.  (a) Western blot 
analysis demonstrating that endogenous expression of occludin is induced by the treatment 
with RAR agonists and 5’Aza-dC/TSA.  AC2M2 cells were treated with atRA (lane 1), 
Am580 (lane 2), 5’Aza-dC (lane 3), as well as 5’Aza-dC and TSA (lane 4).  Densitometric 
analyses for independent triplicate experiments are shown below the representative images, 
and the signal of occludin is defined as 100% in AC2M2-Oc (Oc) cells without the treatments.  
N/D, not detectable.  (b and c) AC2M2 cells were exposed to 25 μM H2O2 for 5 days with or 
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without 1 M atRA or 100 nM Am580 (b), and 1 M 5’Aza-dC and/or 100 nM TSA (c) in 
the presence (+) or absence (-) of 100 nM occludin-specific siRNA.  SA-β-gal (left panel) 
and Ki67 (right panel) positive cells were assessed after the treatments.  *: p<0.05 vs. cells 
without siRNA transfection. 
 
Figure 6.  Occludin induces cellular senescence in vivo.  Representative results of the 
SA-β-gal staining in tumors developed from AC2M2-Vec (Vec) and AC2M2-Oc (Oc) cells in 
mice (a), and quantification of SA-β-gal (left panel) and Ki67 (right panel) positive cells in 
the tissue sections (b).  SA-β-gal staining was positive in 0 of 24 tumors that developed 
from AC2M2-Vec cells (0%) and in 8 of 27 tumors that developed from AC2M2-Oc cells 
(29%; p<0.05).  Bar, 200 μm.  *: p<0.05 vs. cells without occludin transfection. 






